| Authors: |
Saraff V; Birmingham Women's and Children's Hospital, Birmingham, UK. vrinda.saraff@nhs.net., Arango-Sancho P; Sant Joan de Déu Barcelona Hospital, Barcelona, Spain., Bacchetta J; Hospices Civils de Lyon, Lyon, France., Boot AM; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Burren CP; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Chinoy A; Royal Manchester Children's Hospital, Manchester, UK., Dharmaraj P; Alder Hey Children's Hospital, Liverpool, UK., Gómez Llorente MA; Hospital Virgen de Las Nieves, Granada, Spain., González Rodríguez JD; Department of Pediatric Nephrology, Santa Lucia General University Hospital, Cartagena, Spain., Gueorguieva I; Centre Hospitalier Universitaire de Lille, Lille, France., Hayes W; Great Ormond Street Hospital, London, UK., Schnabel D; Center for Chronic Sick Children, Pediatric Endocrinology, Charité - University Medicine Berlin, Berlin, Germany., Duro HR; Pediatric Nephrology, Vall d'Hebron University Hospital, Barcelona, Spain., Davies EH; Aparito Ltd, a Wholly Owned Subsidiary of Eli Lilly &Co., Wrexham, UK., Komarzynski S; Aparito Ltd, a Wholly Owned Subsidiary of Eli Lilly &Co., Wrexham, UK., Rylands AJ; Kyowa Kirin International, Marlow, UK., Sandilands K; Kyowa Kirin International, Marlow, UK., Ishii H; Kyowa Kirin Co., Ltd., Tokyo, Japan., Williams A; Kyowa Kirin International, Marlow, UK., Selveindran S; Open Health Ltd, Marlow, UK., Barlassina A; Open Health Ltd, Marlow, UK., Bowden A; Spire Outcomes Limited, London, UK., Linglart A; Paris Saclay University, AP-HP, INSERM Bicêtre Paris Saclay Hospital, Le Kremlin Bicêtre, Paris, France. |
